Atai Life Sciences Research and Development Expenses 2020-2024 | ATAI
Atai Life Sciences research and development expenses from 2020 to 2024. Research and development expenses can be defined as an expense arising from studies and product development processes.
Atai Life Sciences Annual Research and Development Expenses
(Millions of US $) |
| 2024 |
$55 |
| 2023 |
$62 |
| 2022 |
$75 |
| 2021 |
$63 |
| 2020 |
$23 |
| 2019 |
$13 |
Atai Life Sciences Quarterly Research and Development Expenses
(Millions of US $) |
| 2024-12-31 |
$19 |
| 2024-09-30 |
$12 |
| 2024-06-30 |
$13 |
| 2024-03-31 |
$12 |
| 2023-12-31 |
$14 |
| 2023-09-30 |
$13 |
| 2023-06-30 |
$15 |
| 2023-03-31 |
$19 |
| 2022-12-31 |
$22 |
| 2022-09-30 |
$19 |
| 2022-06-30 |
$18 |
| 2022-03-31 |
$15 |
| 2021-12-31 |
$20 |
| 2021-09-30 |
$13 |
| 2021-06-30 |
$24 |
| 2021-03-31 |
$7 |
| 2020-12-31 |
$15 |
| 2020-09-30 |
$3 |
| 2020-06-30 |
$3 |
| 2020-03-31 |
$2 |
| 2019-12-31 |
|
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Outpatient & Home Care |
$0.278B |
$0.000B |
|
atai Life Sciences B.V. is a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders. atai Life Sciences B.V. is based in BERLIN.
|
